Join us in celebrating Dr. Golub at the 12th Annual “People who Make a Difference in Human Health” ICTS Awards Dinner
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
View this email in your browser
ICTS-AI Banner

2020 Pathways to Cures:
Translational Science Research Day

Announcing the
2020 Clinical Translational Scientist
Career Achievement Award Recipient

Sidney Golub, PhD

This award honors the career accomplishments of an investigator who embodies excellence in the broad spectrum of translational science from basic and applied research to implementing biomedical discovery to clinical practice. The common theme of this award is consistent and outstanding achievement in translational innovation that benefits human health.

Dr. Sidney Golub received his BA from Brandeis University, his PhD in microbiology from Temple University School of Medicine, and was a Damon Runyon Memorial Fund Postdoctoral Fellow at the Department of Tumor Biology of the Karolinska Institute in Stockholm, Sweden where he studied tumor immunology. Golub was appointed to the faculty of the UCLA School of Medicine in 1971 where his research focused on the functions of the immune system in cancer patients. In his administrative career, Golub served for six years at UCLA as an Associate Dean of Medicine and then for more than two years as Interim Dean of the UCLA School of Medicine. From 1994 to 1998 Golub was the Executive Vice Chancellor at UCI where he was the campus chief academic and operating officer. From 1999 to 2003, Sidney Golub served as the Executive Director of the Federation of American Societies for Experimental Biology (FASEB) in Bethesda, MD. Golub retired from FASEB in 2003 to return to UCI where he focused on issues of science policy and research ethics. Golub has published over 150 items, including over 100 peer reviewed scientific articles, and holds several patents. He was awarded the Jonsson Prize for Cancer Research in 1991. Dr. Golub’s laboratory research program followed two closely related themes: the in vitro regulation of cytotoxic cells by cell interactions, cytokines, and other regulatory factors and the in vivo expression of cytotoxic cell function in cancer patients. The major focus of these studies was on the regulation and expression of cytotoxicity by human Natural Killer (NK) lymphocytes including the function of lymphocytes at the tumor site (tumor infiltrating lymphocytes, or TILs) as these cells represent the immune response at the interface with the malignant cells.

His current interests focus on research ethics and science policy issues; In particular, how we make and implement policy on human stem cells. One aspect of this interest is exploring the differences between California and other states on stem cell policy. A related interest focuses on how to promote ethical principles within basic and translational research. He currently directs the Clinical Research Ethics Unit of the UCI Institute for Clinical and Translational Science and chaired the UCI Human Stem Cell Research Oversight Committee since its inception in 2005 until 2013. He also served from 2003 to 2013 on the UCI Institutional Review Board (IRB) overseeing clinical research. Golub was the Interim Director of the Sue & Bill Gross Stem Cell Research Center at UCI from 2013 to 2017. He is currently an active member of the national Clinical Research Ethics Consultation Collaborative. Golub served on the Board of Trustees of Smith College of Northampton from 2003-2013 and chaired their committee on Academic Affairs.

Join us in celebrating Dr. Golub at the 12th Annual
“People who Make a Difference in Human Health”
ICTS Awards Dinner

Tuesday, June 2, 2020
The Cove at UCI Beall Applied Innovation
5270 California Avenue Irvine, CA 92617

Event Website | Register Here